Vansen Pharma Inc logo

VNSN - Vansen Pharma Inc Share Price

$0.03 0.0  0.0%

Last Trade - 03/09/19

Sector
Basic Materials
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £523k
Position in Universe th / 6395
Bullish
Bearish
Unlock VNSN Revenue
Momentum
Relative Strength (%)
1m +2,094%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2007 2008 2009 2010 2011 2012 2013E 2014E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2013, Vansen Pharma Inc revenues increased from $0K to $682K. Net loss increased from $30K to $2.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects General and administrative increase from $11K to $1M (expense). Basic Earnings per Share excluding Extraordinary Items totaled to -$0.04.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

VNSN Revenue Unlock VNSN Revenue

Net Income

VNSN Net Income Unlock VNSN Revenue

Normalised EPS

VNSN Normalised EPS Unlock VNSN Revenue

PE Ratio Range

VNSN PE Ratio Range Unlock VNSN Revenue

Dividend Yield Range

VNSN Dividend Yield Range Unlock VNSN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
VNSN EPS Forecasts Unlock VNSN Revenue
Profile Summary

Vansen Pharma Inc., formerly Okana Ventures, Inc., is an integrated healthcare sales and marketing organization focused on acquiring specialty pharmaceutical products and stable cash flow healthcare businesses. The Company’s products include Factive, Spectracef, Cefditoren Pivoxil and Prednisolone 25. The Company acquired the product rights for Factive (Gemifloxacin Mesylate) tablets from Merus Labs International Inc. Factive is a fluoroquinolone antibiotic approved for the treatment of acute bacterial exacerbations of chronic bronchitis (ABECB) and community-acquired pneumonia of mild to moderate severity (CAP).

Directors
Last Annual December 31st, 2012
Last Interim September 30th, 2013
Incorporated May 9, 2005
Public Since October 15, 2007
No. of Shareholders: 35
No. of Employees: n/a
Sector Basic Materials
Industry Metals & Mining
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 91,297,178
Free Float (0.0%)
Eligible for
ISAs
SIPPs
VNSN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for VNSN
Upcoming Events for VNSN
Frequently Asked Questions for Vansen Pharma Inc
What is the Vansen Pharma Inc share price?

As of 03/09/19, shares in Vansen Pharma Inc are trading at $0.03, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Vansen Pharma Inc share price performed this year?

Shares in Vansen Pharma Inc are currently trading at $0.03 and the price has moved by 2.63k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Vansen Pharma Inc price has moved by 2.38k% over the past year.

What are the analyst and broker recommendations for Vansen Pharma Inc?

There are no analysts currently covering Vansen Pharma Inc.

When will Vansen Pharma Inc next release its financial results?

Vansen Pharma Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2014-09-30
What is the Vansen Pharma Inc dividend yield?

Vansen Pharma Inc does not currently pay a dividend.

Does Vansen Pharma Inc pay a dividend?

Vansen Pharma Inc does not currently pay a dividend.

When does Vansen Pharma Inc next pay dividends?

Vansen Pharma Inc does not currently pay a dividend.

How do I buy Vansen Pharma Inc shares?

To buy shares in Vansen Pharma Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Vansen Pharma Inc?

Shares in Vansen Pharma Inc are currently trading at $0.03, giving the company a market capitalisation of £n/a.

Where are Vansen Pharma Inc shares listed? Where are Vansen Pharma Inc shares listed?

Here are the trading details for Vansen Pharma Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: VNSN
What kind of share is Vansen Pharma Inc?

We were not able to load our ranking data for Vansen Pharma Inc

Is there a Vansen Pharma Inc share price forecast 2020?

We were not able to load any forecast data for Vansen Pharma Inc.

How can I tell whether the Vansen Pharma Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vansen Pharma Inc. Over the past six months, the relative strength of its shares against the market has been 2.69k%. At the current price of $0.03, shares in Vansen Pharma Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Vansen Pharma Inc PE Ratio?

We were not able to find PE ratio data for Vansen Pharma Inc.

Who are the key directors of Vansen Pharma Inc?

Vansen Pharma Inc's management team is headed by:

Dennis Petke - PRE
Who are the major shareholders of Vansen Pharma Inc?

Here are the top five shareholders of Vansen Pharma Inc based on the size of their shareholding:

Similar to VNSN
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.